Jeff Herrera
About Jeff Herrera
Jeff Herrera is a Clinical Account Executive at ANI Pharmaceuticals, Inc. with a strong background in neuroscience sales and extensive experience in launching pharmaceutical products in the rare disease sector.
Work at ANI Pharmaceuticals
Jeff Herrera currently serves as a Clinical Account Executive at ANI Pharmaceuticals, Inc. He has held this position since 2022, contributing to the company's efforts in the pharmaceutical sector. His role involves managing clinical accounts and fostering relationships with healthcare providers to enhance product visibility and accessibility.
Previous Experience in Pharmaceuticals
Prior to his current role, Jeff Herrera worked at Supernus Pharmaceuticals, Inc. in various capacities. He served as a Regional Account Manager for Neuroscience from 2018 to 2021, and briefly as a Senior Sales Representative in 2021. He also held the position of Regional Director for the West Coast for six months in 2021-2022. His experience in these roles has equipped him with a strong foundation in sales and account management within the pharmaceutical industry.
Background in Women's Healthcare
Jeff Herrera worked as a Women's Healthcare Representative at Vertical Pharmaceuticals from 2015 to 2018. During his time in this role, he focused on promoting pharmaceutical products specifically designed for women's health, enhancing his expertise in this specialized area of healthcare.
Education and Expertise
Jeff Herrera studied at The University of Kansas, where he earned a Bachelor's degree in Economics. He also completed his secondary education at Rockhurst High School. His educational background supports his extensive experience in sales and account management, particularly in the neuroscience and rare disease sectors.
Achievements in Product Launches
Jeff Herrera played a key role in the initial launch of Cortrophin Gel, a product aimed at patients with chronic autoimmune disorders. This launch targeted multiple states, including Colorado, Utah, Wyoming, and Nebraska, showcasing his ability to manage complex product introductions in the pharmaceutical market.